How many drugs treat Diabetic renal disease?

Drug Landscape tracks 5 marketed treatments for Diabetic renal disease (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/diabetic-renal-disease.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Diabetic renal disease — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetic renal disease (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Diabetic renal disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Avapro	IRBESARTAN HYDROCHLORIDE	Sanofi	Angiotensin 2 Receptor Blocker [EPC]	Type-1 angiotensin II receptor	1997-01-01
Avapro	IRBESARTAN	Sanofi	Angiotensin 2 Receptor Blocker [EPC]	Type-1 angiotensin II receptor	1997-01-01
Cozaar	losartan	Merck & Co.	ARB (Angiotensin II receptor blocker)	AT1 receptor	1995-04-14
Cozaar	LOSARTAN POTASSIUM	Merck & Co.	Angiotensin 2 Receptor Blocker	Type-1 angiotensin II receptor	1995-01-01
Capozide 25/15	CAPTOPRIL	Aarxion Anda Hlding	Thiazide Diuretic [EPC]	Renin	1981-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck & Co. · 2 drugs in Diabetic renal disease
Sanofi · 2 drugs in Diabetic renal disease
Aarxion Anda Hlding · 1 drug in Diabetic renal disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Diabetic renal disease:

Cite this brief

Drug Landscape (2026). Diabetic renal disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/diabetic-renal-disease. Accessed 2026-06-10.

Diabetic renal disease full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing